Seaport Therapeutics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Daphne Zohar has disclosed a beneficial ownership of 9.1% in Seaport Therapeutics, Inc., holding over 5.2 million shares.